Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PARP inhibitors in castration-resistant prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PARP inhibitors in castration-resistant prostate cancer.
PARP inhibitors in castration-resistant prostate cancer. Cancer Treat Res Commun. 2020; 24:100199.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Biomarkers, Tumor
Clinical Decision-Making
Clinical Decision-Making
DNA Repair
DNA Repair
Drug Approval
Drug Approval
Humans
Humans
Indoles
Indoles
Male
Male
Patient Selection
Patient Selection
Phthalazines
Phthalazines
Piperazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Prostatic Neoplasms, Castration-Resistant
Prostatic Neoplasms, Castration-Resistant
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Synthetic Lethal Mutations
Synthetic Lethal Mutations